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Gamma-secretaseProcessing of β-amyloid precursor protein (APP) by β- and γ-secretases in neurons produces amyloid-β
(Aβ), whose excess accumulation leads to Alzheimer's disease (AD). Knowledge on subcellular trafﬁcking
pathways of APP and its fragments is important for the understanding of AD pathogenesis. We designed fusion
proteins comprising a C-terminal fragment of APP (app) and ﬂuorescent proteins GFP (G) andDsRed (D) to permit
the tracking of the fusion proteins and fragments in cells. CAD cells expressing these proteins emitted colocalized
green and red ﬂuorescence and produce ectodomains, sGapp and sRapp, and Aβ, whose level was reduced by in-
hibitors of β- and γ-secretases. The presence of GappR in endosomeswas observed via colocalization with Rab5.
These observations indicated that the fusion proteins were membrane inserted, transported in vesicles and
proteolytically processed by the same mechanism for APP. By attenuating fusion protein synthesis with
cycloheximide, individual ﬂuorescent colors from the C-terminus of the fusion proteins appeared in the
cytosol which was strongly suppressed by β-secretase inhibitor, suggesting that the ectodomains exit the cell
rapidly (t1/2 about 20 min) while the C-terminal fragments were retained longer in cells. In live cells, we
observed the ﬂuorescence of the ectodomains located between parental fusion proteins and plasmamembrane,
suggesting that these ectodomain positions are part of their secretion pathway. Our results indicate that the
native ectodomain does not play a decisive role for the key features of APP trafﬁcking and processing and the
new fusion proteins may lead to novel insights in intracellular activities of APP.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Current evidence supports the idea that excess level of brain
amyloid-β peptide (Aβ) is the primary driving force in the pathogenesis
of Alzheimer's disease (AD) [1,2]. Hence studying those factors involved
in regulating Aβ production is pivotal for understanding the develop-
ment and treatment of the disease. Aβ, mainly peptides of 40 or 42s of APP; GappR, GFP-APP106-
PP; sRapp, soluble DsRed-APP;
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l rights reserved.amino acids, is generated from the sequential proteolytic cleavage of a
membrane protein, β-amyloid precursor protein (APP), by two mem-
brane proteases, β-secretase (memapsin 2, BACE1) and γ-secretase.
Within the normal brain, Aβ production and clearance are strictly regu-
lated for ﬁne tuning synaptic function and homeostasis [3]. However,
mutations in APP that result in an over production of Aβ, such as the
Swedish mutation of APP [4,5] or mutations in γ-secretase that disrupt
the Aβ40:Aβ42 ratio, lead to the development of the inherited form of
AD [6,7]. Such genetic linkages suggest the importance of maintaining
Aβ homeostasis in normal brain functions. The fact that two established
risk factors for sporadic AD, ApoE4 [8,9] and SorLA [10] function in
cellular trafﬁcking of APP further illustrated the importance of vesicular
transport of APP in Aβ homeostasis and AD pathogenesis.
APP is a single chain type I transmembrane glycoproteinwith a large
ectodomain that contains several subdomains, such as the cupric ion
binding domain and the Kunitz type protease inhibitor domain. The
processing of APP by β-secretase, at a site located 29 residues from
the transmembrane domain, produces the ectodomain fragment,
commonly referred as soluble APP (sAPP), and a C-terminal fragment
(C99) that consisted of both the transmembrane and the intracellular
domains. Processing of APP C99 fragment by γ-secretase at a sitewithin
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tracellular domain (AICD). γ-Secretase is ubiquitously present in the
membranes of all cellular compartments and efﬁciently cleaves newly
generated C99 in the cells (Fig. 1A). Thus, an important step in the reg-
ulation of Aβ production is the transport and localization of APP and
β-secretase at subcellular compartments where optimal cleavage may
take place. Evidence has shown that Aβ production is highly dependent
on the cellular trafﬁcking patterns of both APP and β-secretase [11–13].
These proteins are synthesized in the ER, post-translationally modiﬁed
in the Golgi and transported to the cell surface where APP may be
cleaved by α-secretase thereby excluding the formation of Aβ [14]. Al-
ternatively, APP may be internalized with β-secretase into the
endosomal system where the acidic interior of the vesicles optimally
facilitates β-secretase activity, resulting in APP cleavage leading to
Aβ generation [11,15]. After the full process, APP fragments sAPP
and Aβ are transported outside of the cells by unknownmechanisms.
Among all these steps, the endocytosis of APP appears to be a partic-
ularly important process in the regulation of Aβ production.
Several regulatory mechanisms involving the internalization of APP
have been reported. Like other type 1membrane proteins, APP contains se-
quence motifs in its cytosolic domain that bind various adaptor proteins.
Such interactions not only play a pivotal role in packaging APP in transport
vesicles for internalization and cellular trafﬁcking, but they also provide
sites for regulation of these processes [16,17]. APP is also phosphorylat-
ed at several cytoplasmic sites, most notably Thr743 (APP770Fig. 1. cDNA construction and expression of GappR and RappG in CNS catecholaminergic CAD
GFP and DsRed were cloned into the pSecTag 2B vector containing an N-terminal IgK leader
sites: β-secretase, α-secretase and γ-secretase (arrows) as well as an intact C-terminal dom
or RappG for a 24 h period. Antibodies against APP (1560, recognizes Aβ 1-17), GFP and Ds
respondswith themodiﬁed apps predictedmoleculeweight (75 kDa). C. CAD cells were transfe
using the Zeiss confocal microscope 63× objective. Most cells were positive for both GFP and
DsRedﬂuorescence colocalizedwith each other suggesting an intact app. D. Under similar condi
of Aβ. (Scale bar: 20 μm in size).numbering), which results in alterations in binding FE65, an important
modulator of APP processing and the physiological function of the AICD
[17,18]. In addition, most cellular APP is found in the Golgi network,
suggesting the presence of a Golgi retention mechanism which may
participate in regulating the release of APP to the cell surface.
Current understanding on the trafﬁcking of APP and its fragments
in cells is still incomplete. Not only the structural requirements of APP
for its trafﬁcking and processing are poorly understood, but also the
intracellular pathways for the trafﬁcking of APP fragments are largely
obscure. Commonly used methods to study these topics are frequently
based on immunohistological staining, which have limited sensitivity
and are also ineffective for studying living cells. Previously, Kaether
and Gerdes developed a GFP-tagged APP C100-based construct to
study the cellular site for γ-secretase cleavage [19]. While informative,
this construct had only limited ability in accessing the locale and kinetics
of β-secretase cleavage. Furthermore as the label was placed only on the
C-terminus of the APP fragment, the visualization of soluble APPwas not
feasible. To overcome these deﬁciencies, we sought to create APP con-
structs that contain intrinsic ﬂuorophores at both termini. Importantly,
these modiﬁcations should not interfere with the normal processing of
APP through the amyloidogenic and non-amyloidogenic pathways.
Such APP derivatives would provide information on the structural re-
quirements for APP trafﬁcking and processing. In this paper, we report
the design and characterization of such a system used in the studies of
APP transport and processing.cells. A. To generate the GappR or RappG, the last 106 amino acids of APP770 as well as
sequence. The modiﬁed app contains amino acids 665–770 including all three secretase
ain and Aβ peptide. B. Immunoblotting of cell lysate following transfection with GappR
Red demonstrated a prominent band between the 55 and 78 kDa markers, which cor-
cted for a 24 h period afterwhich cells were ﬁxed andmounted on slides for visualization
DsRed ﬂuorescence indicating proper expression of the protein. In addition, the GFP and
tions as C., GFP andDsRedﬂuorescence colocalizedwith APP 1560 suggesting the presence
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2.1. Construction of modiﬁed APPs
The GappR construct contains the last 318 bases of APP which was
fused directly with the DsRed cDNA from the pDsRed2-C1 vector
(Clontech) to form the appR construct. The appR cDNAwas subcloned
into a pEGFP-C1 vector (Clontech) thereby generating the GappR. The
GappR was subsequently subcloned into a secretion vector, pSecTag
2B (Invitrogen). RappG construction was similar to the GappR except
for the reversal in GFP and DsRed ﬂuorophores as well as the use of site
directed mutagenesis (Quickchange XL, Stratagene) for correction in
alignment of the RappG. Sequence analysis of both GappR and RappG
revealed correct sequence and alignment. Tables 1 and 2 found in the
supplementary data have the list of primers used for construction of
GappR and RappG. Vector for Gapp construct encodes a fusion protein,
containing the green ﬂuorescence protein (G) and the last 106 amino
acids of APPsw695, inserted in the pSecTag2B vector. The Gapp con-
struct was generated by ampliﬁcation of the Gapp cDNA from the
GappR construct using forward primer 5 ttggatccgtgagcaagggcgagg-3′
and reverse primer 5′-ttctcgagctagttctgcatctgc-3′.
2.2. Cell culture and transfection of GappR or RappG
Mouse neuronal CAD cell line (a gift from Dr. D. M. Chikaraishi,
Duke University) was cultured in DMEM/F12 (Fisher) containing
10% fetal bovine serum and 2% penicillin/streptomycin [20]. Transient
transfectionswere performed using FugeneHD (followingmanufacture's
protocol) (Roche) and 2 μg of cDNA for a 12, 24 or 48 h.
2.3. Chemicals, inhibitors and antibodies
GRL-8234 and DAPT (Sigma Aldrich) were separately dissolved in
DMSO to concentrations of 12 μM and 1 μM respectively. Cycloheximide
was used at a concentration of 100 μg/mL (Sigma-Aldrich). For immuno-
chemical detections, antibodies and dilutions are: GFP (Sigma-Aldrich),
1:4000; DsRed (Clontech), 1:200; APP 1560 (Abcam), 1:2000; actin
(Abcam), 1:4000; and phosphor-Thr 743 of APP (Invitrogen), 1:500.
2.4. ELISA
Aβ40 was analyzed using a Human Aβ40 ELISA kit (Invitrogen)
following manufacture's protocol and quantitated in a BioRad 680XR
plate reader.
2.5. Western blot
Cells were collected from 6-well plates and lysed in a PBS solution
containing 1% NP40, 0.1% SDS, and 1:100 protease inhibitors
(Calbiochem). Western blots consisted of steps of PAGE on 10% tricine
gel, transferred to a PDVF membrane, and visualized using an ECL kit
(Thermo scientiﬁc, Pierce).
2.6. Cell viability
Cell viability was determined in a 24 h post transfection of GappR or
RappG using the CCK8 counting kit (Dojindo). Trypan blue exclusion
was used to assess cell viability after treatment with 100 100 μg/mL
cycloheximide for 30 h.
2.7. Subcellular localization
CAD cells were plated on 25 mm glass cover slips (VWR) treated
with BD Cell-Tak™ (BD Bioscience). Following transient transfection
with GappR or RappG, cells were ﬁxed in 4% paraformaldehyde,
mounted on 25 × 75 mm 1.0 mm slides (VWR) using Sure-mountwithDapi (50 μl at 10 mg/mL) and visualized by a Zeiss confocalmicro-
scope using the 63× water objective. For co-staining the transfected
cells with APP 1560 (1:500) (Abcam), GM130 (Abcam), Lamp2
(Abcam) or EEA1 (Abcam) cells were permeabilized with 0.2% saponin
for 15 min at room temperature followed by antibody incubation for
1 h. Secondary antibody, Alexaﬂuor 647 (Invitrogen) goat anti mouse/
rabbit was used (1:400) for detection of the above listed antibodies.
2.8. Zeiss confocal microscope ﬁxed cell imaging of processed APP
CAD cells were plated on 25 mm glass cover slips (VWR) treated
with BD Cell-Tak™ (BD Bioscience). Following transient transfection
with GappR or RappG, and subsequent treatments with cycloheximide,
cells were ﬁxed in 4% paraformaldehyde, mounted on 25 × 75 mm
1.0 mm slides (VWR) using Sure-mount with Dapi (50 μl at 10 mg/mL)
and visualized by a Zeiss confocal microscope using the 63× water
objective.
2.9. Epiﬂuorescent microscope (Zeiss, Axiovert 200M) live cell imaging of
processed APP
CAD cells were plated on Willco-Dish glass bottom plated
(Willcowells) followedby subsequent treatments. For population studies,
snapshots were taken randomly for groups of cells over a 1 h period.
Fluorescence was quantitated using the AxioVision software which
assessed the average ﬂuorescent intensity in each cell. Subtraction of
background ﬂuorescence generated the adjusted ﬂuorescent value. The
ratio of C99/sAPPβ (DsRed/GFP) was calculated based on the adjusted
values of each ﬂuorophore. A total of 77 cells in two independent exper-
imentswere done. For visualization of GappR andRappG cleavage events,
cells were randomly chosen based onmorphological appearance and im-
ageswere taken for 3 h every 5 min and ﬂuorescencewas quantitated as
above which assigned an average ﬂuorescent value to the designated
region of interest for each image taken per series. The ﬂuorescent inten-
sities of both GFP and DsRed were assigned and the ratio of each at
the given time point was calculated. We averaged three experimental
points for each condition and plotted the ﬂuorescent ratio (sAPPβ/C99)
over a 3 h time course using 20 min time points. All images were
captured using the epiﬂuorescent microscope (Zeiss, Axiovert 200M)
with CO2/heated chamber and a 40× objective lens.
2.10. Statistics
Statistical parameters were assessed using a one-way ANOVA or
Student's t-test. Values below p b 0.05 were considered signiﬁcant.
3. Results
3.1. Construction and expression of cDNAs for GappR and RappG
The new APP derivative was designed to contain a central APP
fragment, app, with two different ﬂuorescence proteins, GFP (G)
and DsRed (R), fused to the two ends to form either GappR or
RappG (Fig. 1A). These new fusion proteins will test whether APP
trafﬁcking and processing can be monitored in real time thereby gen-
erating a useful tool for examining the intracellular activities of APP.
An important question we sought to answer is if the fused ﬂuorescent
proteins are folded correctly and thus can be followed in cells. The
availability of two new proteins with G and R at the inverted positions
will serve as conﬁrmation to each other in later studies of their pro-
cessing and transport. The app segment, which is derived from the
C-terminal 106 amino acids of the 770 residue APPSwedish (residues
665–770) (Fig. 1A), contains processing sites by three secretases, the
transmembrane domain and the cytosolic tail. The app segment also
contains those residues known to be preferred for substrate recognition
by β-secretase [21,22]. Thus, the processing of the new ﬂuorogenic
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the transport of various fragments, and the production of intact Aβ can
be followed by their ﬂuorescence.
The cDNA's of GappR or RappGwere inserted into the vector pSecTag
2B, which contains an IgK leader sequence upstream of multiple cloning
sites (Fig. 1A). The expression of GappR or RappG proteins in CAD cells
from the respective vectors was assessed by Western blot analysis
using antibodies for DsRed, and GFP. We observed positive bands corre-
sponding to a size of 65 kDa (Fig. 1B), which agreed with the expected
size for GappR or RappG. Confocal microscopy images of CAD cells
transfected with either GappR or RappG showed green and red ﬂuores-
cence from the expressed GFP and DsRed moieties, and a substantial
colocalization of the two images after merging (Fig. 1C). In addition,
ﬂuorescence fromGFP andDsRed colocalizedwith antibody 1560 speciﬁc
for residues 1–17 of Aβ (Fig. 1D) conﬁrming that the intact GappR con-
tains the Aβ species. Together, these observations indicate the successful
expression and folding of new proteins GappR and RappG in CAD cells.
3.2. GappR and RappG undergo normal proteolytic processing and post-
translational modiﬁcation of APP
To ensure that the GappR and RappG proteins are able to properly
function in cells like the native APP, we investigated their fragments
of proteolytic processing and post-translational modiﬁcation. CAD
cells transiently transfected with GappR or RappG vectors and cultured
for 24 h produced Aβ40 at a level over 20 folds higher than those in
untransfected controls (Fig. 2A). The inclusion of 12 μM GRL-8234, a
potent β-secretase inhibitor (βi) [23] or 1 μM DAPT, a γ-secretase in-
hibitor (γi), in the culture medium of the transfected cells resulted in
about 90% inhibition of Aβ production (Fig. 2A), while the inclusion of
solvent DMSO without the inhibitors produced no inhibition (Fig. 2A;
Supplemental Fig. 1). In addition, we also observed in the Western blot
of culture medium a 33 kDa band corresponding to the ectodomain of
GappR, sGappβ, which is a direct product of β-secretase cleavage of
GappR (Fig. 2B). This band was absent when β-secretase inhibitor
GRL-8234 was added to the culture medium (Fig. 2B), conﬁrming that
it was the cleavage product of β-secretase. These ﬁndings suggest that
similar to native APP, GappR and RappG are processed normally by
β-secretase and γ-secretase through the amyloidogenic pathway.
In the non-amyloidogenic pathway, APP is cleaved ﬁrst by
α-secretase to generate a secreted sAPPα fragment and a membrane
tethered C83 fragment. The latter is further processed by γ-secretase to
produce a p3 fragment and the AICD. In Western blots of the culture
medium of cells expressing GappR, using antibody 1560 which recog-
nizes only sGappα but not sGappβ, we observed a 35-KDa band corre-
sponding to the predicted size of sAPPα (Fig. 2B). In the presence of
β-secretase inhibitor GRL-8234, the intensity of the sAPPα band is in-
creased by about 4 fold compared to those samples containing no inhib-
itor (Fig. 2B). These comparisons indirectly substantiated the identity of
the sAPPα bands as it is well known that the suppression of the
amyloidogenic pathwaywould result in the elevation of APP processing
through the non-amyloidogenic pathwaymediated byα-secretase [24].
APP contains eight phosphorylation sites on its C-terminal cytosolic
tail, one of which, threonine 743 (APP770 numbering) has been shown
to be themajor phosphorylation site in APP [18]. FromWestern analyses
using a phospho-speciﬁc antibody that recognizes the sequence
surrounding the phosphate group at Thr743, we found that both
GappR and RappG are phosphorylated (Fig. 2C). The above observations
indicate that GappR and RappG retainmany of the processing and phos-
phorylation functions of APP in the cells.
3.3. Intracellular localization of GappR
Examined under a confocal microscope, the ﬂuorescence of GappR
expression in CAD cells produced punctate, vesicular-like bodies in
the perinuclear region (Fig. 3A). These GappR-vesicle like structuresdid not colocalize with the late endosome/lysosome marker Lamp2
nor the Golgi marker GM130 (Fig. 3B). They also colocalize poorly
with endosomemarker EEA1 (data not shown). It is known, however,
that APP and EEA1 colocalize poorly in some cultured neuronal cells
and not at all in other neuronal cell lines [25,26]. To examine the
colocalization of GappR with early endosomes in CAD cells, the Rab5
antibody was employed following GappR transfection. At a 6 h post
transfection, we observed clear colocalization of the two proteins
(Fig. 3C). Interestingly, less extent of colocalization was found in ex-
pression periods of 12 h or longer. This appeared to be due to the dis-
parity between the high ﬂuorescence intensity from GappR and
relatively weak ﬂuorescence intensity from Rab5. The above observa-
tions are consistent with the intracellular localization of GappR in
endosomes.
3.4. Visualization of GappR and RappG processing through confocal
microscopy
GappR expressed in CAD cells and its proteolytic products should
be distinguishable when examined with confocal microscopy. While
GappR is expected to have colocalized GFP and DsRed ﬂuorescence,
the proteolytic fragments alone should produce images of a single
ﬂuorophore. We observed initially intense colocalized green and red
ﬂuorescence within most cytosolic areas in the cells but only a few
small areas of single ﬂuorescence (Fig. 3A). In order to increase the
chance for observing the fragments, we attempted to shift the
synthetic/degradation dynamics using protein synthesis inhibitor
cycloheximide (CHX), which had been successfully employed for this
purpose previously [27]. We investigated CHX dosage as related to the
inhibition of GappR synthesis (Supplementary Fig. 2) which provided
a range ofworkable conditions for further experiments. Confocalmicro-
scopic images of GappR expressed in the presence of CHX showed clear
green or red vesicular-like areas in the cytosolic region at the 6 h and
12 h time points (Fig. 4A). These observations suggest that the attenu-
ated protein synthesis with CHX improved the observation of GappR
cleavage products sGappβ (green vesicles) and C99R (red vesicles).
To ensure that CHX addition did not alter the mechanism of APP
processing, we set out to detect Aβ in those cells treated with CHX
(Fig. 4B). Cells were transfected with GappR and cultured for 12 h in
the presence or absence of β-secretase inhibitor GRL-8234 or
γ-secretase inhibitor DAPT. After which, CHX was added for 6 h, and
the media collected for the determination of Aβ. As expected, CHX re-
duced Aβ by about 40% as compared to control (Fig. 4B). Combination
of CHX with secretase inhibitors further reduced Aβ, indicating that a
substantial capacity of APP processing was still functioning in the pres-
ence of CHX. In another series of experiments, culture media from cells
treated as described abovewere replacedwith CHX freemedia ormedia
with the inhibitor additives and Aβ accumulated over the next 25 hwas
measured. Cells which had been treatedwith CHX produced only about
10% of Aβ as compared with the CHX free control (Fig. 4B). This differ-
ence is expected as CHX had inhibited the synthesis and accumulation
of GappR in the previous period. Signiﬁcantly, secretase inhibitors fur-
ther inhibited Aβ level in the CHX treated cells. These observations sug-
gest that the APP processing apparatus in the cells was functional
during or after CHX treatment, thus, it would be possible to follow the
localization, processing and transport of GappR in CHX treated cells.
3.5. Visualization of GappR and RappG processing through the use of live
cell imaging
The results presented above suggest that using the developed GappR
and RappG expression system, the dynamic processes of APP cleavage
and transport may now be followed in live cells using the epiﬂuorescent
microscope (Zeiss, Axiovert 200M) with environmental chamber. Our
initial attempt was aimed at capturing cellular images of green or red
ﬂuorescence which provide visual markers for the processing of
Fig. 2. GappR and RappG are processed through the amyloidogenic and non-amyloidogenic pathways as well as undergo post-translational modiﬁcation on Thr 743. A. CAD cells
transfected with GappR or RappG for a 24 h period had detectable levels of Aβ production in the cell media. Further conﬁrmation of this came from the use of a β-secretase inhibitor
GRL-8234 (βi) and γ-secretase inhibitor DAPT (γi). Both inhibitors halt the amyloidogenic pathway thereby reducing the production of Aβ. B. Schematic showing the speciﬁc epitopes for
GFP andAPP 1560 antibodies. In termsof the sGapps, GFP is able to recognize both sGappα and sGappβ, however, APP 1560will only recognize sGappα. Immunoblotting for cell lysate and
media after a 48 h transfectionwith GappR. Using antibodies APP 1560 and GFP on cell lysate demonstrated that GappR expression is similar despite the addition of GRL-8234.Moreover,
the cell media showed a decrease in sAPPβ upon addition of GRL-8234, but an increase in sGappα. Conﬁrmation of sGappαwas demonstrated through the use of a speciﬁc antibody, APP
1560, that only recognizes this species. Modest amounts of sGappα exist under normal conditions in the cell media, however, upon addition of GRL-8234, an increase in this product is
detecteddue to the inhibition of the amyloidogenic pathway. C. Schematic representing theC-terminal domainof APP. In bold are the two signaturemotifs VTPEER andYENPTY. Themajor
APP phosphorylation site occurs at Thr743,which is part of the VTPEERmotif.Westernblot conﬁrmed the ability ofGappR and RappG to be phosphorylated at their C-terminal Thr743 site.
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from the merge of green and red ﬂuorescence showed signiﬁcant inten-
sity of red ﬂuorescence, indicating the presence of C99-DsRed fragment
in the cells (Fig. 5A) which substantiated the presence of GappR process-
ing. Conversely, the addition of GRL-8234 resulted in a merged image
that was essentially yellow, indicating similar intensities for both the
GFP and DsRed ﬂuorophores. The presence of both GFP and DsRed in
the cell suggests that the processing of GappR was suppressed by the
β-secretase inhibitor (Fig. 5A). The ratio for red and green ﬂuorescence
in an individually chosen cell from a non-treated and inhibitor treated
condition was calculated (Fig. 5B). Similar calculations were done for
all 77 cells in both conditions and plotted on a scatter plot (Fig. 5C).
The DsRed to GFP ratio was greater in GappR transfected cells compared
to cells with inhibitor (p b 0.001). Furthermore, 68% control cells had the
red/green ratios greater than 2, this fraction was only 27% in cells with
inhibitor (p b 0.001) (Fig. 5 D). Since it is known that sAPP is secreted
from the cells, the loss of green ﬂuorescence from GappR processing sug-
gests that the sGapp fragment is rapidly removed from the cells, possibly
by secretion, and the other fragment C99R is retained.3.6. Course of GappR and RappG processing observed through live
cell imaging
We next attempted to observe the course for the processing of
GappR by β-secretase in living cells using the established conditionsdescribed above. CAD cells were transiently transfected with GappR
and cultured for 12 h in the absence or presence of β-secretase inhib-
itor GRL-8234, then in the presence of CHX for 16 h. Cells were then
observed for GFP and DsRed ﬂuorescence for 3 h in 30 min intervals.
We observed a signiﬁcant and steady decrease in GFP ﬂuorescence in
control cells within the ﬁrst hour but remained the same thereafter
(Fig. 6A). In the presence of GRL-8234, there was no signiﬁcant loss of
GFP ﬂuorescence (Fig. 6A), again indicating the loss of GFP ﬂuorescence
wasmediated byβ-secretase. To substantiate these results,we repeated
this experiment using cells transfected with RappG and found a loss of
DsRed ﬂuorescence in control cells in the initial 60 min which was
very similar to that observed for GappR in the experiment above.
Again, inhibitor GRL-8234 abolished the DsRed loss (Fig. 6B). These ob-
servationswere veriﬁedwith quantitative data on ratios of two ﬂuores-
cence intensities (Fig. 6C). In the presence of inhibitor GRL-8234, the
ratios of ﬂuorescence from GappR and RappG remained near 1:1
throughout the 3 h observation period, indicating that little processing
had taken place. In the control experiments, the decline of ﬂuorescence
ratios, which reﬂects the loss of C-terminal C99 moiety, leveled off at
about 0.55.3.7. Visualization of sGapp and sRapp through the use of live cell imaging
When APP is cleaved by β-secretase in the endosomes, the soluble
N-terminal ectodomain, sAPPβ, is released from the membrane
Fig. 3. GappR forms punctate like vesicle structure in the cytoplasm some of which correspond to Rab 5 positive vesicles. A. CAD cells were transfected for a 24 h period after which
cells were ﬁxed and mounted on slides for visualization using the Zeiss confocal microscope 63× objective. Most cells expressed punctate like vesicle staining in the cytoplasm. B.
Under similar conditions as A., co-staining with GM130 Golgi marker or Lamp2 lysosomal marker revealed very little colocalization with GappR. C. CAD cells transfected for 6 h
were co-stained with Rab5 early endosomal marker. Colocalization between GappR and Rab 5 (arrows) indicated localization of GappR in early endosomes.
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system for sAPPβ has not been observed and its mechanism remains
obscure. The data presented above indicate that, during the cleavage
of GappR or RappG by β-secretase, the N-terminal fragments, sGappβ
or sRappβ, which are equivalent to sAPPβ in APP, are rapidly removed
from the cell. Therefore, we sought to observe, as a model of sAPPβ,
the transport of sGappβ and sRappβ using live cells expressing
GappR or RappG. CAD cells were transiently transfected and cultured
for 12 h, followed by incubation in the presence of CHX for 2–6 h,
then observed under an epiﬂuorescent microscope. We assumed
that the subcellular components involved in the transport of these
two fragments will emit a single color in a ﬂuorescence microscope,
green for sGappβ and red for sRappβ. We observed in some cells
patches of vesicle-like structures within the cytosolic region of the
cells for both app constructs (Fig. 7A). Theywere clearly distinguishable
from those containing uncleaved GappR or RappG which emitted two
ﬂuorescent signals (yellow after merge). Interestingly, these red/green
areas were found on one side of the cells adjacent to the large area of
unprocessedGappR or RappG (Fig. 7A, yellowmerged areas) but bridging
toward theplasmamembrane (Fig. 7A). Using confocalmicroscopy, these
vesicle-like structures showed poor colocalization with Lamp2, a knownmarker for late endosomes/lysosomes (Fig. 7B). These results suggest
that the red/green areasmay be part of a transport system and this secre-
tion activity is polarized in cells.
4. Discussion
Results presented above indicate that in the new APP fusion proteins
expressed in CAD cells, the ﬂuorophore moieties, GFP and DsRed, were
correctly folded to yield green and red ﬂuorescence respectively. In the
subcellular areas where ﬂuorescence from two ﬂuorophores colocalized,
the intensities of the two ﬂuorophores were similar suggesting that the
ﬂuorophores at the two ends of the new proteins are both functional.
Moreover, the successful transit of the fusion proteins through the
secretory and endocytic pathways supports the correct folding
since the incorrectly folded proteins are known to be retained by
the endoplasmic reticulum. Our data also indicated that the fusion
proteins were inserted into the membrane with the app moiety rec-
ognized by the same cellular mechanisms involved in the transport
and processing of native APP. We not only observed the expected
GappR and RappG fragments processed by β- and γ-secretases
(Figs. 1 and 2), but also the inclusion of speciﬁc and potent inhibitors
Fig. 4. Addition of CHX enhances detection of sGapp and C99R fragments derived from the processing of GappR. A. CAD cells were transfected for a 24 h period after which cells
were untreated or treated with 100 ug/mL of CHX for 2, 6 or 12 h. Cells were ﬁxed and mounted on slides for visualization using the Zeiss confocal microscope 63× objective.
Most cells expressed punctate like vesicle staining in the cytoplasm. Treated samples expressed enhanced distinct GFP or DsRed ﬂuorescence indicative of sGapp or C99R respec-
tively. B. CAD cells were transfected for a 12 h period after which cells were untreated or treated with 100 ug/mL of CHX for either 6 h or 26 h in the presence of APP inhibitors
GRL-8234 or DAPT. Aβ production was not inhibited with the addition of cycloheximide.
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fragments as well as Aβ. In addition, the inhibition of β-secretase led
to a higher level of processing of the fusion proteins by α-secretase,
which is a well known compensatory response in APP processing in
cells by these two secretases [17]. The fact that GappR and RappG are
phosphorylated at Thr-743 as in native APP also substantiates the
correct folding and transport of the fusion proteins. Since APP and
its processing secretases are membrane associated proteins, our
data suggest that the app moiety of the protein is inserted into the
cell membrane with the same topological relationships to these pro-
teases as for the native APP and the fusion proteins are transported
to the appropriate subcellular compartments for APP processing.
These observations also suggest that the ectodomain does not play a de-
cisive role in the key features of APP trafﬁcking and processing. In addi-
tion, the fusion of ﬂuorescent proteins to the C-terminal does not
signiﬁcantly impede the trafﬁcking and processingmechanisms of APP.
Even though the fusion proteins retained the trafﬁcking pathway
of APP, some changes in the quantitative subcellular distribution
may be anticipated. We saw a clear difference in the level of APP
and the fusion proteins in the Golgi. It is well known that under the
normal conditions, about 90% of cellular APP is in the Golgi which
seems to serve as a reservoir of APP supply to cell surface and
endosomes [17]. For GappR and RappG, however, little colocalization
was seen for these fusion proteins with Golgi marker GM130indicating that the GFP or DsRed moiety may affect app retention. In-
stead, most of the GappR and RappG were found to be located in
unidentiﬁed punctate like vesicle structures within the cell (3a). Inter-
estingly, a similar construct (Gapp) lacking the C-terminal ﬂuorophore,
DsRed, was constructed and functioned similar to native APP. The Gapp
produced Aβ and showed strong Golgi retention indicating that the
C-terminal tail of APP may play a role in its recognition or release
fromGolgi (Supplemental Fig. 3). Although themechanismof this effect
is not yet clear, the reduced Golgi retention of the fusion proteins does
not seriously impact on the original goal of our study since the intracel-
lular transport pathway of APP to be studied by the new proteins re-
mains intact.
Our initial attempt to follow the processing of the new fusion
proteins was to observe the processed fragments by taking advantage of
their single green or red ﬂuorescence. However, in CAD cells expressing
either GappR or RappG, nearly all of the green and red ﬂuorescent lights
were colocalized (Fig. 4) at different time points after transfection (data
not shown). Signiﬁcant cellular areas with single ﬂuorescence corre-
sponding to the C-terminal fragments were seen, however, after the
attenuation of protein synthesis with cycloheximide (Fig. 4). The effect
of cycloheximide on APP processing and trafﬁcking is predictably mul-
tifaceted. In the untreated cells, the level of the unprocessed fusion
proteins appears to be in great excess of the processed fragments and
the overpowering ﬂuorescence from the fusion protein prevented an
Fig. 5. Addition of CHX results in production of C99R in CAD which is inhibited by GRL-8234. A. Representative population of CAD cells transfected in the absence or presence of
GRL-8234 for 12 h followed by an additional 18 h with CHX treatment. GappR expressing cells show predominantly red only staining indicating the presence of C99R. Addition
of GRL-8234 results in blockage of GappR cleavage by β-secretase, thereby resulting in an accumulation of intact (yellow) protein containing both GFP and DsRed ﬂuorescence.
B. Representative calculation (AxioVision software) for the DsRed:GFP ratio used in panel C to plot all 77 samples. C. Quantitation of DsRed:GFP ﬂuorescent ratio in CAD cells
under the above conditions using AxioVision software. Those cells expressing GappR show higher levels of DsRed only staining compared to the GRL-8234 treated cells. D.
Graph representing the percent of cells greater than a 2 fold increase in the DsRed:GFP ratio. Those cells treated with GRL-8234 had fewer cells that expressed solely DsRed whereas
the nontreated cells had an abundant number of cells expressing DsRed only.
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effects, cycloheximide should reduce the cellular level of fusion proteins
to permit amore clear observation of the C-terminal fragments. Regard-
less which effects are operative, it is important to point out that the in-
hibition of protein synthesis may affect the dynamics but not the
fundamental mechanism of the processing and transporting systems
for the fusion proteins. Thus, the observations made in cycloheximide
treated cells can still be a model for APP processing and transport in
untreated cells. We saw little change in the intensity of these single
ﬂuorescence areas up to 36 h (results not shown). Since the resolution
of the ﬂuorescence microscope was not sufﬁciently high to observe in-
dividual secretion vesicles, it is more likely that the observed vesicular
ﬂuorescent areas containing C99 represent subcellular regions, such as
endosomes, with a relative abundance of this fragment.
The capturing of ﬂuorescent images representing C-terminal frag-
ments is supported by the following observations. While the expression
of RappG produced subcellular areas of singular green ﬂuorescence, the
expression of GappR produced predominantly red ﬂuorescence, indi-
cating that this ﬂuorescence comes from the ﬂuorophores in the
C-terminal C99-containing fragments. The presence of the single
red/green areas was suppressed by speciﬁc inhibitors for β- or
γ-secretases, indicating that these C-terminal fragments were the
products of these two secretases through the amyloidogenic pathway.
Moreover, the change in the ratio of the two ﬂuorophores in live cellsat different times after the removal of β-secretase inhibitor (Fig. 6) is
also consistent with the above interpretations. These results suggest
that the cellular retention of the N- and C-terminal fragments from
β-secretase processing was not the same and the N-terminal fragment,
sGapp or sRapp, had a shorter residence time than their C-terminal
counterparts. Since sAPP is known to be secreted into the medium, it
seems probable that the relatively fast disappearance of sGapp and
sRapp from the cells is due to the secretion of these fragments.
Using the combination of an early transfection expression period
and a short cycloheximide inhibition, we observed ﬂuorescence cor-
responding to sGapp and sRapp in live cells (Fig. 7). The identity of
these fragments was again veriﬁed by the change of red and green
ﬂuorescence with the use of two different fusion constructs. It is in-
teresting that these ﬂuorescent areas are mostly located between
the fusion protein areas (colocalized green and red, presumably
endosomes) and the plasmamembrane. We observed that these struc-
tures showed little colocalization with the Lamp2, a late endosome/
lysosome marker suggesting that the majority of visible sAPP is not
accumulating in the degradative pathway. However, these structures
do not have the expected properties of the transport vesicles for
sAPP. First, they are fairly stationary in their positions as contrast to the
highly mobile nature expected of the secretary vesicles. Second, most of
these structures are larger in size than expected for transportation vesi-
cles. In addition, these structures have a steady level of ﬂuorescence
Fig. 6. Live cell imaging of Gapp and Rapp processing in CAD cells. A. Representative population of CAD cells transfected with GappR in the absence or presence of GRL-8234. Live cell
imaging over a 3 h period demonstrated a loss of GFP ﬂuorescence in nontreated cells compared to the GRL-8234 treated cells indicating GappR processing. B. Representative pop-
ulation of CAD cells transfected with RappG in the absence or presence of GRL-8234. Live cell imaging over a 3 h period demonstrated a loss of DsRed ﬂuorescence in nontreated
cells compared to the GRL-8234 treated cells indicating RappG processing. C. Graphical representation for A and B, representing the ratio of sAPPβ/C99 over a 3 h period. Both
GappR and RappG demonstrated equal app processing kinetics with peak reduction occurring at the 60 min time point.
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greenﬂuorescence. This suggests that there is a stable steady state ofﬂuo-
rescent content in these structures. A possible explanation for their iden-
tity is that they are the ‘transfer stations’ for the secretion of sAPP. It is
well known that the endosomal system contains assemble centers.Fig. 7. Visualization of sGapp and sRapp through the use of live cell imaging. A. CAD cells wer
presence of CHX for 2–6 h, then observed under a ﬂuorescencemicroscope. Punctate green or r
polarized accumulation of sGapp and sRapp respectively. B. Similar to A, the polarized accumulThus, it is reasonable that ‘transfer stations’ may serve to channel the
N-terminal fragments to different cellular destinations. The fact that we
did not observe the mobile transport vesicles is not surprising since
they have been difﬁcult to observe in all phases of intracellular trafﬁcking
and the resolution of the live cellmicroscopy is not expected to have suche transfected with GappR or RappG and cultured for 12 h, followed by incubation in the
ed only vesicleswere pronounced in the cytoplasmic region of these cells demonstrating a
ation of sGapp shows weak colocalization with Lamp2, a late endosome/lysosomemarker.
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demonstrate the potentials of using these ﬂuorescent APP derivatives as
tracking device and suggest for the ﬁrst time a secretion mechanism for
sAPP that can be further studied in detail. The usefulness of the former
has been further demonstrated in a separate study in which the Golgi
residence of APP and Gapp was perturbed by guanidinium compounds
(Chung, Cooley, Huang, He and Tang, Abstract of the Neuroscience
meeting, 2009, and manuscript submitted for publication). The ﬂuo-
rescence of Gapp was a convenient tool in assessing such cellular
redistribution.
5. Conclusions
The endosomal system plays a key role in APP processing and its
regulation, intimate to the pathogenesis of Alzheimer's disease, is of
great scientiﬁc and medical interests. However, a serious problem in
studying APP trafﬁcking is the difﬁculty to accurately and sensitively
identify the location of APP while it transits through the secretory
pathway, endocytic pathway and processing steps. Classical methods
including immunohistological stains with APP antibodies not only
lack sensitivity, but they are also inappropriate for detecting APP in
living cells. The fusion APP proteins described here may provide a
way to overcome these limitations. We have shown that the ﬂuores-
cence from the fusion proteins and their fragments can be followed in
cells, including live cells. The authenticity of the ﬂuorescence sources
can be veriﬁed through the use of two reversed constructs. With future
studies to manipulate cellular conditions and to improve observation
resolutions, such constructs will be powerful new tools for studying
the mechanism, regulation and kinetics of APP trafﬁcking.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2013.03.003.
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